发明申请
US20120065178A1 OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES
有权
使用葡萄糖激动剂衍生物进行的眼科治疗选择性分析前列腺分期组织
- 专利标题： OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES
- 专利标题（中）： 使用葡萄糖激动剂衍生物进行的眼科治疗选择性分析前列腺分期组织
-
申请号： US13299215申请日： 2011-11-17
-
公开(公告)号： US20120065178A1公开(公告)日： 2012-03-15
- 发明人: Jeffrey L. Edelman , Kelly M. Harrison
- 申请人： Jeffrey L. Edelman , Kelly M. Harrison
- 专利权人： Allergan, Inc.
- 当前专利权人： Allergan, Inc.
- 主分类号： A61K31/56
- IPC分类号： A61K31/56 ; A61K31/58 ; A61P27/02 ; A61K31/573
摘要：
Ophthalmically therapeutic materials, such as liquid-containing compositions and polymeric drug delivery systems, include a therapeutic component that includes an Glucocorticoid Derivative which, upon delivery to the posterior segment of a mammalian eye, does not significantly diffuse to the anterior segment of said eye. Methods of making and using the present materials are also described.